Does the antisecretory peptide AF-16 reduce lung oedema in experimental ARDS?

Background: Acute respiratory distress syndrome (ARDS) is an acute inflammatory condition with pulmonary capillary leakage and lung oedema formation. There is currently no pharmacologic treatment for the condition. The antisecretory peptide AF-16 reduces oedema in experimental traumatic brain injury...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Ups J Med Sci
Main Authors: Barrueta Tenhunen, Annelie, Massaro, Fabrizia, Hansson, Hans Arne, Feinstein, Ricardo, Larsson, Anders, Perchiazzi, Gaetano
Formáid: Artigo
Teanga:Inglês
Foilsithe: Taylor & Francis 2019
Ábhair:
Articles
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6968528/
https://ncbi.nlm.nih.gov/pubmed/31701794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/03009734.2019.1685029
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla